<code id='5C3A8D63DD'></code><style id='5C3A8D63DD'></style>
    • <acronym id='5C3A8D63DD'></acronym>
      <center id='5C3A8D63DD'><center id='5C3A8D63DD'><tfoot id='5C3A8D63DD'></tfoot></center><abbr id='5C3A8D63DD'><dir id='5C3A8D63DD'><tfoot id='5C3A8D63DD'></tfoot><noframes id='5C3A8D63DD'>

    • <optgroup id='5C3A8D63DD'><strike id='5C3A8D63DD'><sup id='5C3A8D63DD'></sup></strike><code id='5C3A8D63DD'></code></optgroup>
        1. <b id='5C3A8D63DD'><label id='5C3A8D63DD'><select id='5C3A8D63DD'><dt id='5C3A8D63DD'><span id='5C3A8D63DD'></span></dt></select></label></b><u id='5C3A8D63DD'></u>
          <i id='5C3A8D63DD'><strike id='5C3A8D63DD'><tt id='5C3A8D63DD'><pre id='5C3A8D63DD'></pre></tt></strike></i>

          Home / Wikipedia / comprehensive

          comprehensive


          comprehensive

          author:fashion    Page View:6751

          Editor’s note: A recording of the event is embedded below.

          After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.

          advertisement

          Featured Speakers

          • Irena Melnikova, Ph.D., partner, Pfizer Ventures
          • Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
          • Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In